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OBJECTIVES: To develop and test a modular questionnaire for
the measurement and valuation of all relevant aspects of pro-
ductivity costs to be applied in economic evaluations of health
care programmes and occupational interventions. METHODS:
Modifying existing instruments and developing new ones, we con-
structed a comprehensive modular measurement instrument cov-
ering absence from work, compensation mechanisms, efﬁciency
losses and productivity costs on the level of organisations.
RESULTS: PRODISQ (PRODuctivity and DISease Question-
naire) has integrated, modiﬁed and further validated instruments
such as the Health and Labour Questionnaire (HLQ), the QQ-
instrument for efﬁciency loss and the compensation questions as
developed by Severens. In addition new instruments were devel-
oped and tested. PRODISQ has the following modules: 1) General
information (demography etc); 2) Profession, working situation
and income; 3) Absence from work during the last 3 months; 4)
Compensation mechanisms in case of absence for paid work; 5)
Productivity costs at work (efﬁciency loss); 6) Productivity costs
at the organisational level; and 7) Administrative and manage-
ment costs. This summer PRODISQ will available for free on the
internet. As compared to other existing instruments, one can say
that PRODISQ is a comprehensive instrument, covering all rele-
vant aspects of productivity costs: Absence from work, compen-
sation mechanisms, efﬁciency loss, the link with the type of work
and other employers costs. PRODISQ has been successfully tested
in several Dutch populations of patients and workers: Patients
with low back pain, dyspepsia, chronic fatigue syndrome (CFS),
psoriasis and rheumatoid arthritis; construction workers and
workers in several industrial companies. We will present key
results concerning validity and relevance of productivity costs.
CONCLUSIONS: All elements of productivity costs can be mea-
sured in a valid way. Many elements turn out to have a relevant
impact on productivity costs for different populations of patients
and/or workers.
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OBJECTIVES: Off-label use and adherence problems can occur
when there are systematic differences between physicians’ and
patients’ perceptions and regulators’ explicit or implicit judg-
ments regarding relative risks and beneﬁts. The objective of this
study is to quantify subjective risk-beneﬁt tradeoffs to inform
risk-management decision making. METHODS: Stated-Prefer-
ence (SP) methods, such as conjoint analysis elicit patient and
physician assessments of hypothetical risk-beneﬁt tradeoffs
provide a necessary common utility metric for comparing risks
to beneﬁts. We administered a web-enabled SP survey to a con-
venience sample of health-care professionals registered for a
major epidemiology conference (N = 444). The instrument
required subjects to complete 6 tradeoff tasks involving paired
hypothetical pain medications relative to a constant, standard-
treatment option. Background risks were set to approximate
mean male population myocardial infarction (MI) risks. Efﬁcacy,
MI risks, and costs were varied according to a D-optimal statis-
tical design. RESULTS: Part-worth utility weights were estimated
using conditional logit analysis. All parameters were statistically
signiﬁcant at the 0.01 level or better. “Somewhat-controlled”
and “well-controlled” efﬁcacy were signiﬁcantly different (p =
0.005), but there was no signiﬁcant difference between “well-
controlled” and “fully-controlled” efﬁcacy levels. Maximum
acceptable risk (MAR) is the increase in risk that exactly offsets
the increase in utility from improved pain control. Mean MAR
for an increase in efﬁcacy from somewhat-controlled to well-con-
trolled is 0.0385, or about 15 times background risk. The cor-
responding mean estimate for maximum acceptable cost or
willingness to pay (WTP) is $1465 per month. CONCLUSIONS:
A convenience sample of health care professionals provided the-
oretically consistent, well-structured risk-beneﬁt stated prefer-
ences for pain-control therapy. Both MAR and WTP estimates
indicate strong preferences for pain control. However, maximum
acceptable risk is much larger than typical regulatory standards.
Such differences between patient and regulatory risk-beneﬁt
tradeoffs signal potential problems for adherence, off-label use,
and other impediments to effective risk management.
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OBJECTIVES: The visual analogue scale (VAS) is a relatively
simple technique for eliciting health-state valuations. However,
several biases may affect VAS values (e.g. context effects, end-
aversion, and anchoring effects). Moreover, the supposed inter-
val measurement level of VAS mean values has been questioned.
An alternative methodology is introduced based on the ranking
of health states combined with associated scaling methods that
are used to transform aggregate ranking data to interval values.
METHODS: Data were collected in a Dutch EuroQol EQ-5D
valuation study, in which a representative sample (n = 212) from
the Dutch population valued a set of 17 EQ-5D health states.
Three computational steps were undertaken: 1) Euclidean dis-
tance measures between each pair of health states were computed
based on individual VAS values; 2) These measures were trans-
formed to ranks; and 3) Non-metric multidimensional scaling
(MDS) was applied for scaling (monotone transformations) the
ranks on one dimension. RESULTS: The analysis supports un-
dimensionality of the raw VAS data, with 94% of the variance
explained with one dimension. Scaling of ranked distances
between health states using MDS produced metric values that
were nearly identical to mean VAS valuations, with the rank-
based values explaining 98% of the variance in the VAS. CON-
CLUSION: Ordinal ranks implied by VAS values, transformed
using scaling techniques, provide strong concordance with mean
VAS values. Our methodology based on simple ordinal ranking
exercises may offer a useful approach for quantifying health-
state valuations in a more feasible and bias-free manner.
However, the selection of the set of health states may affect our
ranking based methodology, and the ﬁndings must be conﬁrmed
based on directly-elicited ranking data. Therefore, further
research is needed to investigate the performance of this new
methodology.
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OBJECTIVES: Every year in Germany more than 25.000 men
are diagnosed with prostate cancer. Theoretically all these
